All In Biotech

Drug Trial Radar · NCT02407782

Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults

Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults: a Cluster Multicenter Randomized Trial

Last checked: Nov 20, 2026Latest source record: Jun 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,092 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,092

Actual

Start

Jan 19, 2016

Primary completion

Dec 16, 2021

Study completion Jan 18, 2022

Sponsor

Lead sponsor
University Hospital, BordeauxAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 3, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Scabies remains a frequent condition that affects adults and children. The aim of this study is to compare the efficacy and safety of two drug treatments against scabies in children and their close contacts. One group will apply topical permethrin 5% and the other group will receive oral ivermectin. Both groups will be treated twice, once at inclusion and the second time 10 days later. Both treatment regimens have been used widely and are safe to use.

Conditions

  • Scabies

Interventions

  • IvermectinDrug

    oral ivermectin, 200μg/kg given at baseline and at day 10.

  • PermethrinDrug

    topical permethrin 5% cream applied at baseline and at day 10.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of skin lesions and healing at day 28Time frame: Day 28

Locations

29 sites in 2 countries. Site status is shown where the registry gives one.

  • APHP- Bobigny - Avicenne

    Bobigny, France

  • CHU de Bordeaux - Saint André

    Bordeaux, France

  • CHU de Brest

    Brest, France

  • CHD Vendée

    La Roche-sur-Yon, France

  • CH Le Havre

    Le Havre, France

  • CHRU de Lille

    Lille, France

  • AP-HM

    Marseille, France

  • APHP Hôpital Cochin

    Paris, France

  • CH de Périgueux

    Périgueux, France

  • CHU de Reims

    Reims, France

  • CHU de Rouen

    Rouen, France

  • CHU de Saint-Etienne

    Saint-Etienne, France

  • CHU de Bordeaux Hôpital Pellegrin

    Bordeaux, Aquitaine, France

  • CHU de Lyon

    Bron, Auvergne-Rhône-Alpes, France

  • CHG de Chalon sur Saône

    Chalon-sur-Saône, Bourgogne-Franche-Comté, France

  • CHU de Dijon

    Dijon, Bourgogne-Franche-Comté, France

  • CHU de Rennes

    Rennes, Brittany Region, France

  • CHRU de Tours

    Tours, Centre-Val de Loire, France

  • CH d'Argenteuil

    Argenteuil, Île-de-France Region, France

  • CHU de Créteil - Hôpital Henry Mondor

    Créteil, Île-de-France Region, France

  • AP-HP - Hôpital Robert Debré

    Paris, Île-de-France Region, France

  • CHU de Montpellier

    Montpellier, Languedoc-Roussillon, France

  • CHU de la Réunion

    Saint-Pierre, Martinique, France

  • CHU d'Angers

    Angers, Pays de la Loire Region, France

  • CH du Mans

    Le Mans, Pays de la Loire Region, France

  • CHU de Nantes

    Nantes, Pays de la Loire Region, France

  • CHI de Fréjus

    Fréjus, Provence-Alpes-Côte d'Azur Region, France

  • CHU de Nice

    Nice, Provence-Alpes-Côte d'Azur Region, France

  • CHU de Pointe à Pitre

    Pointe-à-Pitre, Guadeloupe

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.